Nabriva Therapeutics plc (NBRV) financial statements (2022 and earlier)

Company profile

Business Address 25-28 NORTH WALL QUAY
DUBLIN, D01 H104
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:47,90041,60086,600102,20086,90083,900
Cash and cash equivalents47,65941,35986,019102,00386,76932,778
Short-term investments161617522511051,106
Other undisclosed cash, cash equivalents, and short-term investments225225406(28)2116
Receivables9,3211751,2143,8715,4025,561
Inventory, net of allowances, customer advances and progress billings14,5095,823682   
Inventory14,5095,823682   
Prepaid expense5,1555,8801,1581,1541,5581,176
Contract with customer, asset   1,500
Other undisclosed current assets3,3803,7401,51628(21)(16)
Total current assets:80,26557,21891,170108,75393,83990,621
Noncurrent Assets
Nontrade receivables 370378428425420
Property, plant and equipment2337682,4741,1391,327519
Intangible assets, net (including goodwill)31809198172270
Intangible assets, net (excluding goodwill)31809198172270
Other noncurrent assets380     
Deferred tax assets, net  1,410
Total noncurrent assets:6441,2182,9431,6651,9242,619
TOTAL ASSETS:80,90958,43694,113110,41895,76393,240
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18,20115,73316,63917,80613,26015,877
Accounts payable4,3722,8894,6733,3045,1362,551
Accrued liabilities13,82912,84411,96614,5028,12413,308
Taxes payable     18
Deferred revenue374750 
Debt3,7652,041    
Total current liabilities:22,34018,52416,63917,80613,26015,877
Noncurrent Liabilities
Long-term debt and lease obligation4,2655,68634,50223,718232 
Long-term debt, excluding current maturities4,2655,68634,50223,718232 
Liabilities, other than long-term debt9541,0911,698264203107
Other liabilities9541,0911,698264203107
Total noncurrent liabilities:5,2196,77736,20023,982435107
Total liabilities:27,55925,30152,83941,78813,69515,984
Stockholders' equity
Stockholders' equity attributable to parent, including:53,35033,13541,27468,63082,06877,256
Common stock567211945670 2,939
Additional paid in capital648,432579,123517,044461,911360,872279,149
Accumulated other comprehensive income272727272710
Accumulated deficit(595,676)(546,226)(476,742)(393,978)(279,198)(204,842)
Other undisclosed stockholders' equity attributable to parent    367 
Total stockholders' equity:53,35033,13541,27468,63082,06877,256
TOTAL LIABILITIES AND EQUITY:80,90958,43694,113110,41895,76393,240

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues28,8955,0279,4819,6565,3196,482
Revenue, net5,3196,482
Cost of revenue(13,148)(766)(70)   
Cost of goods and services sold (766)(70)   
Gross profit:15,7474,2619,4119,6565,3196,482
Operating expenses(64,275)(70,387)(88,900)(124,031)(79,087)(61,529)
Operating loss:(48,528)(66,126)(79,489)(114,375)(73,768)(55,047)
Nonoperating income (expense)4691,273470(223)492(783)
Investment income, nonoperating 8625549318 
Other nonoperating income (expense)4691,187215(272) 55
Interest and debt expense(901)(4,492)(3,644)(133)(43)(75)
Other undisclosed income from continuing operations before equity method investments, income taxes     343
Loss from continuing operations before equity method investments, income taxes:(48,960)(69,345)(82,663)(114,731)(73,319)(55,562)
Other undisclosed income from continuing operations before income taxes    318 
Loss from continuing operations before income taxes:(48,960)(69,345)(82,663)(114,731)(73,001)(55,562)
Income tax expense (benefit)(490)(139)(101)(49)(1,355)672
Net loss available to common stockholders, diluted:(49,450)(69,484)(82,764)(114,780)(74,356)(54,890)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(49,450)(69,484)(82,764)(114,780)(74,356)(54,890)
Other comprehensive income    17 
Comprehensive loss:(49,450)(69,484)(82,764)(114,780)(74,339)(54,890)
Other undisclosed comprehensive income, net of tax, attributable to parent     50
Comprehensive loss, net of tax, attributable to parent:(49,450)(69,484)(82,764)(114,780)(74,339)(54,840)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: